|This Slide: #4 of 100|
Slide #4. Paulson Capital — Variation Biotechnologies
Paulson Capital (PLCC)
Paulson Capital (Delaware) Corp., a publicly traded Delaware corporation (Nasdaq:PLCC) ("Paulson"), and privately owned Variation Biotechnologies (US), Inc., a Delaware corporation ("VBI"), announced today that they have signed a definitive merger agreement. Under the agreement, VBI will become the operating subsidiary of Paulson and VBI's pre-merger stockholders will acquire shares of Paulson Common Stock that will represent approximately 59% of the outstanding voting power of Paulson capital stock upon consummation of the transactions contemplated by the merger agreement, including a concurrent private placement of Paulson Common Stock with gross proceeds of at least $11,000,000 to certain institutional stockholders of VBI and an additional institutional investor that has been identified.
Paulson Capital (Delaware) is a holding company. Co.'s operating subsidiary, Paulson Investment Company, Inc., is a brokerage firm. Co. provides broker-dealer services in securities on both an agency and a principal basis to its customers who are introduced to RBC Correspondent Services, a division of RBC Capital Markets Corporation, Co.'s clearing organization. Co. also acts as lead underwriter or participating selling group member for securities offerings. In addition, Co. holds securities for investment, with its investment portfolio principally consisting of securities purchased for investment and underwriter warrants.
Open the PLCC Page at The Online Investor »